TGF-βR1 inhibitor Vactosertib or CXCR4 inhibitor AMD3100 synergistically improves the efficacy of anti-PD-L1 to control metastasis and HCC progression[32]. The gene discussed is CD274; the disease is hepatocellular carcinoma.